查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513322

蛋白質體學市場：按組成部分、按應用分類：2024-2035 年全球機會分析和產業預測

Proteomics Market By Component (Reagents, Instruments, Services), By Application (Drug Discovery, Disease Diagnosis, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
2023年全球蛋白質體市場價值為328億美元，預計到2035年將達到1,619億美元，2024年至2035年複合年成長率為14.2%。蛋白質體學是分子生物學的一個分支，重點在於蛋白質及其結構、功能和生物系統內的相互作用。與研究生物體內整個基因組的基因體學不同，蛋白質體學專門針對蛋白質體。蛋白質組是指由細胞、組織和生物體所表達的一組蛋白質。蛋白質體學領域包括旨在了解蛋白質在生物過程中的作用和行為的各種技術和方法，例如蛋白質表現譜、蛋白質-蛋白質相互作用、轉譯後修飾和蛋白質定位。
蛋白質體學市場-IMG1
蛋白質體學市場的成長歸因於蛋白質體學在疾病診斷中的高採用率、技術進步以及生命科學研究的不斷增加。蛋白質體學是對蛋白質的大規模研究，可以全面了解生物系統中蛋白質之間的動態相互作用，並揭示疾病的發病機制和進展。根據國家醫學圖書館2021年發表的一篇論文，癌症蛋白質組學闡明了腫瘤生長和轉移機制研究中的重要資訊，並為臨床適用的生物標記和治療靶點的識別做出了貢獻。隨著質譜和蛋白質微陣列技術等技術的進步，蛋白質體學使研究人員和臨床醫生能夠以前所未有的準確性和靈敏度識別指示特定疾病的生物標記。蛋白質體學市場正在經歷顯著的快速成長，這主要是由於對生命科學領域研究的日益關注所推動。隨著科學認知的加深和技術進步的加速，對蛋白質體學解決方案的需求呈指數級成長。蛋白質體學是對生物系統中蛋白質及其功能的研究，在闡明複雜的細胞機制、疾病途徑和藥物交互作用方面發揮著至關重要的作用。隨著生命科學研究擴展到基因組學、轉錄組學和代謝體學等不同領域，蛋白質體學已成為一種補充工具，為生物系統的複雜運作提供重要見解。例如，國家醫學圖書館 2021 年的一份報告稱，蛋白質體學已成為分子科學的一個重要領域，因為它提供了有關蛋白質身份、表達水平和修飾的寶貴資訊。此外，個人化醫療的興起和對標靶治療的探索正在推動對精確蛋白質分析技術的需求。這推動了對質譜、蛋白質微陣列和生物資訊解決方案等蛋白質組學技術的投資，以開發更準確的診斷工具和治療性介入。蛋白質體學市場按成分、應用和區域進行細分。依組成部分，市場分為試劑、設備和服務。按應用分類，市場分為藥物發現、疾病診斷等。按地區分類，北美（美國、加拿大、墨西哥）、歐洲（德國、法國、英國、義大利、西班牙、其他歐洲國家地區）、亞太地區（日本、中國、澳洲、印度、韓國、其他亞太地區） ）、歐洲（巴西、哥倫比亞、阿根廷、亞太其他地區）、中東和非洲（海灣合作理事會、南非、北非、中東和非洲其他地區）。蛋白質體學市場的主要企業主要企業有 Bio-Rad Laboratories Inc.、Danaher Corporation、Bruker Corporation、Waters Corporation、Perkin Elmer Inc.、Horiba、Merck KGaA、Agilent Technologies Inc.、Li-Cor Inc.。發布作為關鍵發展策略，以改善蛋白質體學市場的產品系列。
  • 本報告定量分析了 2023 年至 2035 年蛋白質組學市場分析的細分市場、當前趨勢、估計/趨勢和動態，並確定了蛋白質組學市場的強大機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析揭示了買家和供應商的潛力，幫助相關人員做出利潤驅動的業務決策並加強供應商和買家網路。
  • 蛋白質體學市場細分的詳細分析有助於識別市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場參與者定位有助於基準化分析，並提供對市場參與者當前地位的清晰了解。
  • 該報告包括對區域和全球蛋白質組市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章蛋白質體學市場：依組成部分

  • 概述
  • 試劑
    • 試劑蛋白質體學市場：按試劑類型
  • 裝置
    • 儀器蛋白質體學市場：依儀器類型
  • 服務

第5章蛋白質體學市場：依應用分類

  • 概述
  • 藥物發現
  • 疾病診斷
  • 其他

第6章蛋白質體學市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2023年主要企業定位

第8章 公司簡介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Waters Corporation
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc.
  • Li-Cor Inc
  • Bruker Corporation
  • Perkin Elmer Inc
  • Danaher Corporation
  • Horiba Ltd.
Product Code: A01352
The global proteomics market was valued at $32.8 billion in 2023 and is projected to reach $161.9 billion by 2035, growing at a CAGR of 14.2% from 2024 to 2035. Proteomics is a branch of molecular biology that focuses on the study of proteins, their structures, functions, and interactions within a biological system. Unlike genomics, which deals with the study of an organism's entire genome, proteomics specifically targets the proteome, which refers to the complete set of proteins expressed by a cell, tissue, or organism. The field of proteomics encompasses various techniques and methodologies aimed at understanding the roles and behaviors of proteins in biological processes, including protein expression profiling, protein-protein interactions, post-translational modifications, and protein localization.
Proteomics Market - IMG1
The proteomics market growth is attributed to high adoption of proteomics in disease diagnosis, technological advancements, and increase in research in life sciences. Proteomics, the large-scale study of proteins, offers a comprehensive understanding of the dynamic interplay between proteins within biological systems, shedding light on disease pathogenesis and progression. According to a 2021 article by National Library of Medicine, it was reported that cancer proteomics unraveled key information in mechanistic studies on tumor growth and metastasis, which has contributed to the identification of clinically applicable biomarkers as well as therapeutic targets. With advancements in technology, such as mass spectrometry and protein microarray techniques, proteomics enables researchers and clinicians to identify biomarkers indicative of specific diseases with unprecedented accuracy and sensitivity. Thus, the increasing adoption of proteomics in disease diagnosis is expected to drive growth of proteomics industry.The proteomics market is experiencing a significant surge, largely driven by the increasing emphasis on research in the life sciences sector. As scientific understanding deepens and technological advancements accelerate, the demand for proteomics solutions has grown exponentially. Proteomics, the study of proteins and their functions within biological systems, plays a pivotal role in elucidating complex cellular mechanisms, disease pathways, and drug interactions. With life sciences research expanding across various disciplines such as genomics, transcriptomics, and metabolomics, proteomics has emerged as a complementary tool offering crucial insights into the intricate workings of biological systems. For instance, according to 2021 report by National Library of Medicine, it was reported that proteomics has become an important field in molecular sciences, as it provides valuable information on the identity, expression levels, and modification of proteins. Moreover, the rise of personalized medicine and the quest for targeted therapies have fueled the need for precise protein analysis techniques. This has propelled investments in proteomics technologies, including mass spectrometry, protein microarrays, and bioinformatics solutions, to develop more accurate diagnostic tools and therapeutic interventions. Thus, the rise in research in the life sciences sector is expected to drive the growth of the market.The proteomics market is segmented on the basis of component, application, and region. By component, the market is divided into reagents, instruments and services. By application, the market is divided into drug discovery, diseases diagnosis, and other. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA).Major key players that operate in the proteomics market are Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., Danaher Corporation, Bruker Corporation, Waters Corporation, Perkin Elmer Inc, Horiba Ltd., Merck KGaA, Agilent Technologies Inc., Li-Cor Inc. Key players have adopted collaboration, and product launch as a key developmental strategy to improve the product portfolio of the proteomics market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the proteomics market analysis from 2023 to 2035 to identify the prevailing proteomics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the proteomics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global proteomics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Component

  • Reagents
    • Reagents Type
    • Microarray
    • X Ray Crystallography
    • Spectrometry
    • Chromatography
    • Electrophoresis
    • Immunoassay
    • Protein Fractionation Reagents
  • Instruments
    • Instruments Type
    • Microarray
    • Spectrometry
    • Chromatography
    • Electrophoresis
    • Surface Plasmon Resonace
    • X Ray Crystallography
    • Protein Fractionation Reagents
  • Services

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Waters Corporation
    • Bio-Rad Laboratories Inc
    • Agilent Technologies Inc.
    • Li-Cor Inc
    • Bruker Corporation
    • Perkin Elmer Inc
    • Danaher Corporation
    • Horiba Ltd.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: PROTEOMICS MARKET, BY COMPONENT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reagents
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Reagents Proteomics Market by Reagents Type
  • 4.3. Instruments
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Instruments Proteomics Market by Instruments Type
  • 4.4. Services
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: PROTEOMICS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Drug Discovery
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Disease Diagnosis
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: PROTEOMICS MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Component
    • 6.2.3. Market size and forecast, by Application
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Component
      • 6.2.4.1.2. Market size and forecast, by Application
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Component
      • 6.2.4.2.2. Market size and forecast, by Application
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Component
      • 6.2.4.3.2. Market size and forecast, by Application
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Component
    • 6.3.3. Market size and forecast, by Application
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Component
      • 6.3.4.1.2. Market size and forecast, by Application
      • 6.3.4.2. France
      • 6.3.4.2.1. Market size and forecast, by Component
      • 6.3.4.2.2. Market size and forecast, by Application
      • 6.3.4.3. UK
      • 6.3.4.3.1. Market size and forecast, by Component
      • 6.3.4.3.2. Market size and forecast, by Application
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Market size and forecast, by Component
      • 6.3.4.4.2. Market size and forecast, by Application
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Market size and forecast, by Component
      • 6.3.4.5.2. Market size and forecast, by Application
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Component
      • 6.3.4.6.2. Market size and forecast, by Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Component
    • 6.4.3. Market size and forecast, by Application
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. Japan
      • 6.4.4.1.1. Market size and forecast, by Component
      • 6.4.4.1.2. Market size and forecast, by Application
      • 6.4.4.2. China
      • 6.4.4.2.1. Market size and forecast, by Component
      • 6.4.4.2.2. Market size and forecast, by Application
      • 6.4.4.3. India
      • 6.4.4.3.1. Market size and forecast, by Component
      • 6.4.4.3.2. Market size and forecast, by Application
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Market size and forecast, by Component
      • 6.4.4.4.2. Market size and forecast, by Application
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Market size and forecast, by Component
      • 6.4.4.5.2. Market size and forecast, by Application
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Component
      • 6.4.4.6.2. Market size and forecast, by Application
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Component
    • 6.5.3. Market size and forecast, by Application
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Component
      • 6.5.4.1.2. Market size and forecast, by Application
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Market size and forecast, by Component
      • 6.5.4.2.2. Market size and forecast, by Application
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Market size and forecast, by Component
      • 6.5.4.3.2. Market size and forecast, by Application
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Market size and forecast, by Component
      • 6.5.4.4.2. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Thermo Fisher Scientific Inc.
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. Merck KGaA
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. Waters Corporation
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. Bio-Rad Laboratories Inc
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. Agilent Technologies Inc.
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Li-Cor Inc
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. Bruker Corporation
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Business performance
    • 8.7.7. Key strategic moves and developments
  • 8.8. Perkin Elmer Inc
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
    • 8.8.7. Key strategic moves and developments
  • 8.9. Danaher Corporation
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
    • 8.9.7. Key strategic moves and developments
  • 8.10. Horiba Ltd.
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance
    • 8.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 02. PROTEOMICS MARKET FOR REAGENTS, BY REGION, 2023-2035 ($MILLION)
  • TABLE 03. GLOBAL REAGENTS PROTEOMICS MARKET, BY REAGENTS TYPE, 2023-2035 ($MILLION)
  • TABLE 04. PROTEOMICS MARKET FOR INSTRUMENTS, BY REGION, 2023-2035 ($MILLION)
  • TABLE 05. GLOBAL INSTRUMENTS PROTEOMICS MARKET, BY INSTRUMENTS TYPE, 2023-2035 ($MILLION)
  • TABLE 06. PROTEOMICS MARKET FOR SERVICES, BY REGION, 2023-2035 ($MILLION)
  • TABLE 07. GLOBAL PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 08. PROTEOMICS MARKET FOR DRUG DISCOVERY, BY REGION, 2023-2035 ($MILLION)
  • TABLE 09. PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2023-2035 ($MILLION)
  • TABLE 10. PROTEOMICS MARKET FOR OTHERS, BY REGION, 2023-2035 ($MILLION)
  • TABLE 11. PROTEOMICS MARKET, BY REGION, 2023-2035 ($MILLION)
  • TABLE 12. NORTH AMERICA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 13. NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 14. NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 15. U.S. PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 16. U.S. PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 17. CANADA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 18. CANADA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 19. MEXICO PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 20. MEXICO PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 21. EUROPE PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 22. EUROPE PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 23. EUROPE PROTEOMICS MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 24. GERMANY PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 25. GERMANY PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 26. FRANCE PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 27. FRANCE PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 28. UK PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 29. UK PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 30. ITALY PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 31. ITALY PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 32. SPAIN PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 33. SPAIN PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 34. REST OF EUROPE PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 35. REST OF EUROPE PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 36. ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 37. ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 38. ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 39. JAPAN PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 40. JAPAN PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 41. CHINA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 42. CHINA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 43. INDIA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 44. INDIA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 45. AUSTRALIA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 46. AUSTRALIA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 47. SOUTH KOREA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 48. SOUTH KOREA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 49. REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 50. REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 51. LAMEA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 52. LAMEA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 53. LAMEA PROTEOMICS MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 54. BRAZIL PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 55. BRAZIL PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 56. SAUDI ARABIA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 57. SAUDI ARABIA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 58. SOUTH AFRICA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 59. SOUTH AFRICA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 60. REST OF LAMEA PROTEOMICS MARKET, BY COMPONENT, 2023-2035 ($MILLION)
  • TABLE 61. REST OF LAMEA PROTEOMICS MARKET, BY APPLICATION, 2023-2035 ($MILLION)
  • TABLE 62. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 63. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 64. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
  • TABLE 65. THERMO FISHER SCIENTIFIC INC.: SERVICE SEGMENTS
  • TABLE 66. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 67. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIES
  • TABLE 68. MERCK KGAA: KEY EXECUTIVES
  • TABLE 69. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 70. MERCK KGAA: PRODUCT SEGMENTS
  • TABLE 71. MERCK KGAA: SERVICE SEGMENTS
  • TABLE 72. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 73. MERCK KGAA: KEY STRATEGIES
  • TABLE 74. WATERS CORPORATION: KEY EXECUTIVES
  • TABLE 75. WATERS CORPORATION: COMPANY SNAPSHOT
  • TABLE 76. WATERS CORPORATION: PRODUCT SEGMENTS
  • TABLE 77. WATERS CORPORATION: SERVICE SEGMENTS
  • TABLE 78. WATERS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 79. WATERS CORPORATION: KEY STRATEGIES
  • TABLE 80. BIO-RAD LABORATORIES INC: KEY EXECUTIVES
  • TABLE 81. BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT
  • TABLE 82. BIO-RAD LABORATORIES INC: PRODUCT SEGMENTS
  • TABLE 83. BIO-RAD LABORATORIES INC: SERVICE SEGMENTS
  • TABLE 84. BIO-RAD LABORATORIES INC: PRODUCT PORTFOLIO
  • TABLE 85. BIO-RAD LABORATORIES INC: KEY STRATEGIES
  • TABLE 86. AGILENT TECHNOLOGIES INC.: KEY EXECUTIVES
  • TABLE 87. AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
  • TABLE 88. AGILENT TECHNOLOGIES INC.: PRODUCT SEGMENTS
  • TABLE 89. AGILENT TECHNOLOGIES INC.: SERVICE SEGMENTS
  • TABLE 90. AGILENT TECHNOLOGIES INC.: PRODUCT PORTFOLIO
  • TABLE 91. AGILENT TECHNOLOGIES INC.: KEY STRATEGIES
  • TABLE 92. LI-COR INC: KEY EXECUTIVES
  • TABLE 93. LI-COR INC: COMPANY SNAPSHOT
  • TABLE 94. LI-COR INC: PRODUCT SEGMENTS
  • TABLE 95. LI-COR INC: SERVICE SEGMENTS
  • TABLE 96. LI-COR INC: PRODUCT PORTFOLIO
  • TABLE 97. LI-COR INC: KEY STRATEGIES
  • TABLE 98. BRUKER CORPORATION: KEY EXECUTIVES
  • TABLE 99. BRUKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 100. BRUKER CORPORATION: PRODUCT SEGMENTS
  • TABLE 101. BRUKER CORPORATION: SERVICE SEGMENTS
  • TABLE 102. BRUKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 103. BRUKER CORPORATION: KEY STRATEGIES
  • TABLE 104. PERKIN ELMER INC: KEY EXECUTIVES
  • TABLE 105. PERKIN ELMER INC: COMPANY SNAPSHOT
  • TABLE 106. PERKIN ELMER INC: PRODUCT SEGMENTS
  • TABLE 107. PERKIN ELMER INC: SERVICE SEGMENTS
  • TABLE 108. PERKIN ELMER INC: PRODUCT PORTFOLIO
  • TABLE 109. PERKIN ELMER INC: KEY STRATEGIES
  • TABLE 110. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 111. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 112. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 113. DANAHER CORPORATION: SERVICE SEGMENTS
  • TABLE 114. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 115. DANAHER CORPORATION: KEY STRATEGIES
  • TABLE 116. HORIBA LTD.: KEY EXECUTIVES
  • TABLE 117. HORIBA LTD.: COMPANY SNAPSHOT
  • TABLE 118. HORIBA LTD.: PRODUCT SEGMENTS
  • TABLE 119. HORIBA LTD.: SERVICE SEGMENTS
  • TABLE 120. HORIBA LTD.: PRODUCT PORTFOLIO
  • TABLE 121. HORIBA LTD.: KEY STRATEGIES

LIST OF FIGURES

  • FIGURE 01. PROTEOMICS MARKET, 2023-2035
  • FIGURE 02. SEGMENTATION OF PROTEOMICS MARKET,2023-2035
  • FIGURE 03. TOP IMPACTING FACTORS IN PROTEOMICS MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN PROTEOMICS MARKET (2024-2035)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL PROTEOMICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. PROTEOMICS MARKET, BY COMPONENT, 2023 AND 2035(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR REAGENTS, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR INSTRUMENTS, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR SERVICES, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 15. PROTEOMICS MARKET, BY APPLICATION, 2023 AND 2035(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR DRUG DISCOVERY, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR OTHERS, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 19. PROTEOMICS MARKET BY REGION, 2023 AND 2035(%)
  • FIGURE 20. U.S. PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 21. CANADA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 22. MEXICO PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 23. GERMANY PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 24. FRANCE PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 25. UK PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 26. ITALY PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 27. SPAIN PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 28. REST OF EUROPE PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 29. JAPAN PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 30. CHINA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 31. INDIA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 32. AUSTRALIA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 33. SOUTH KOREA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 34. REST OF ASIA-PACIFIC PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 35. BRAZIL PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 36. SAUDI ARABIA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 37. SOUTH AFRICA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 38. REST OF LAMEA PROTEOMICS MARKET, 2023-2035 ($MILLION)
  • FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 43. COMPETITIVE DASHBOARD
  • FIGURE 44. COMPETITIVE HEATMAP: PROTEOMICS MARKET
  • FIGURE 45. TOP PLAYER POSITIONING, 2023